The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
Open accessAbstract
Purpose: This joint practice guideline or procedure standard was developed collaboratively by the European Association of Nuclear Medicine (EANM) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI). The goal of this guideline is to assist nuclear medicine practitioners in recommending, performing, interpreting, and reporting the results of dopaminergic imaging in parkinsonian syndromes. Methods: Currently nuclear medicine investigations can assess both presynaptic and postsynaptic function of dopaminergic synapses. To date both EANM and SNMMI have published procedural guidelines for dopamine transporter imaging with single photon emission computed tomography (SPECT) (in 2009 and 2011, respectively). An EANM guideline for D2 SPECT imaging is also available (2009). Since the publication of these previous guidelines, new lines of evidence have been made available on semiquantification, harmonization, comparison with normal datasets, and longitudinal analyses of dopamine transporter imaging with SPECT. Similarly, details on acquisition protocols and simplified quantification methods are now available for dopamine transporter imaging with PET, including recently developed fluorinated tracers. Finally, [18 F]fluorodopa PET is now used in some centers for the differential diagnosis of parkinsonism, although procedural guidelines aiming to define standard procedures for [18 F]fluorodopa imaging in this setting are still lacking. Conclusion: All these emerging issues are addressed in the present procedural guidelines for dopaminergic imaging in parkinsonian syndromes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wardlaw, J. M., Smith, E. E., Biessels, G. J., Cordonnier, C., Fazekas, F., Frayne, R., Lindley, R. I., O'Brien, J. T., Barkhof, F., Benavente, O. R., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70124-8 · Cited by 5,544
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476
Self-citationGraphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,567
(2012) · The Scientific World JOURNAL · doi:10.1100/tswj · Cited by 2,595
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
Höglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., Mollenhauer, B., Müller, U., Nilsson, C., Whitwell, J. L., et al. (2017) · Movement Disorders · doi:10.1002/mds.26987 · Cited by 2,359
Criteria for the diagnosis of corticobasal degeneration
Armstrong, M. J., Litvan, I., Lang, A. E., Bak, T. H., Bhatia, K. P., Borroni, B., Boxer, A. L., Dickson, D. W., Grossman, M., Hallett, M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f0fd1 · Cited by 1,904
The Parkinson Progression Marker Initiative (PPMI)
Marek, K., Jennings, D., Lasch, S., Siderowf, A., Tanner, C., Simuni, T., Coffey, C., Kieburtz, K., Flagg, E., Chowdhury, S., et al. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.09.005 · Cited by 1,892
Self-citationFDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
Boellaard, R., O’Doherty, M. J., Weber, W. A., Mottaghy, F. M., Lonsdale, M. N., Stroobants, S. G., Oyen, W. J. G., Kotzerke, J., Hoekstra, O. S., Pruim, J., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1297-4 · Cited by 1,326
Self-citationHughes, A. J., Ben-Shlomo, Y., Daniel, S. E., & Lees, A. J. (1992) · Neurology · doi:10.1212/wnl.42.6.1142 · Cited by 1,313
MDS research criteria for prodromal Parkinson's disease
Berg, D., Postuma, R. B., Adler, C. H., Bloem, B. R., Chan, P., Dubois, B., Gasser, T., Goetz, C. G., Halliday, G., Joseph, L., et al. (2015) · Movement Disorders · doi:10.1002/mds.26431 · Cited by 1,309
Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
Kordower, J. H., Olanow, C. W., Dodiya, H. B., Chu, Y., Beach, T. G., Adler, C. H., Halliday, G. M., & Bartus, R. T. (2013) · Brain · doi:10.1093/brain/awt192 · Cited by 1,286
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study
Whone, A. L., Watts, R. L., Stoessl, A. J., Davis, M., Reske, S., Nahmias, C., Lang, A. E., Rascol, O., Ribeiro, M. J., Remy, P., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10609 · Cited by 829
Self-citationErlandsson, K., Buvat, I., Pretorius, P. H., Thomas, B. A., & Hutton, B. F. (2012) · Physics in Medicine and Biology · doi:10.1088/0031-9155/57/21/r119 · Cited by 733
McKeith, I., O'Brien, J., Walker, Z., Tatsch, K., Booij, J., Darcourt, J., Padovani, A., Giubbini, R., Bonuccelli, U., Volterrani, D., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70057-1 · Cited by 716
Self-citationBenamer, H. T. S., Patterson, J., Grosset, D. G., Booij, J., de Bruin, K., van Royen, E., Speelman, J. D., Horstink, M. H. I. M., Sips, H. J. W. A., Dierckx, R. A., et al. (2000) · Movement Disorders · doi:10.1002/1531-8257(200005)15:3<503::aid-mds1013>3.0.co;2-v · Cited by 707
Iffland, K., & Grotenhermen, F. (2017) · Cannabis & Cannabinoid Research · doi:10.1089/can.2016.0034 · Cited by 645
Brooks, D. J., Ibanez, V., Sawle, G. V., Quinn, N., Lees, A. J., Mathias, C. J., Bannister, R., Marsden, C. D., & Frackowiak, R. S. J. (1990) · Annals of Neurology · doi:10.1002/ana.410280412 · Cited by 626
Self-citationVolkow, N. D., Fowler, J. S., Logan, J., Alexoff, D., Zhu, W., Telang, F., Wang, G.-J., Jayne, M., Hooker, J. M., Wong, C., et al. (2009) · JAMA · doi:10.1001/jama.2009.351 · Cited by 529
EFNS/MDS‐ES recommendations for the diagnosis of Parkinson's disease
Berardelli, A., Wenning, G. K., Antonini, A., Berg, D., Bloem, B. R., Bonifati, V., Brooks, D., Burn, D. J., Colosimo, C., Fanciulli, A., et al. (2013) · European Journal of Neurology · doi:10.1111/ene.12022 · Cited by 489
Self-citationMattsson, S., Johansson, L. F., Svegborn, S. L., Liniecki, J., Noßke, D., Riklund, K., Stabin, M. G., Taylor, D. M., Bolch, W. E., Carlsson, S., et al. (2015) · Annals of the ICRP · doi:10.1177/0146645314558019 · Cited by 405
Resolution modeling in PET imaging: Theory, practice, benefits, and pitfalls
Rahmim, A., Qi, J., & Sossi, V. (2013) · Medical Physics · doi:10.1118/1.4800806 · Cited by 357
Darcourt, J., Booij, J., Tatsch, K., Varrone, A., Vander Borght, T., Kapucu, Ö. L., Någren, K., Nobili, F., Walker, Z., & Van Laere, K. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1267-x · Cited by 346
Self-citationBrown, R. M., Crane, A. M., & Goldman, P. S. (1979) · Brain Research · doi:10.1016/0006-8993(79)90132-x · Cited by 330
Ichihara, T., Ogawa, K., Motomura, N., Kubo, A., & Hashimoto, S. (1993) · PubMed · Cited by 318
Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging
Frey, K. A., Koeppe, R. A., Kilbourn, M. R., Vander Borght, T. M., Albin, R. L., Gilman, S., & Kuhl, D. E. (1996) · Annals of Neurology · doi:10.1002/ana.410400609 · Cited by 314
Catafau, A. M., & Tolosa, E. (2004) · Movement Disorders · doi:10.1002/mds.20112 · Cited by 290
Orimo, S., Suzuki, M., Inaba, A., & Mizusawa, H. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.01.009 · Cited by 279
Laruelle, M., Wallace, E., Seibyl, J. P., Baldwin, R. M., Zea-Ponce, Y., Zoghbi, S. S., Neumeyer, J. L., Charney, D. S., Hoffer, P. B., & Innis, R. B. (1994) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1994.131 · Cited by 268
Self-citationTossici-Bolt, L., Hoffmann, S. M. A., Kemp, P. M., Mehta, R. L., & Fleming, J. S. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0155-x · Cited by 259
Self-citationPositron Emission Tomography of Monoaminergic Vesicular Binding in Aging and Parkinson Disease
Bohnen, N. I., Albm, R. L., Koeppe, R. A., Wernette, K. A., Kilbourn, M. R., Minoshima, S., & Frey, K. A. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600276 · Cited by 254
Self-citationVarrone, A., Dickson, J. C., Tossici-Bolt, L., Sera, T., Asenbaum, S., Booij, J., Kapucu, O. L., Kluge, A., Knudsen, G. M., Koulibaly, P. M., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2276-8 · Cited by 250
Self-citationSNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0
Djang, D. S. W., Janssen, M. J. R., Bohnen, N., Booij, J., Henderson, T. A., Herholz, K., Minoshima, S., Rowe, C. C., Sabri, O., Seibyl, J., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.100784 · Cited by 247
Self-citationYoshita, M. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00278-5 · Cited by 244
Role of DAT‐SPECT in the diagnostic work up of Parkinsonism
Scherfler, C., Schwarz, J., Antonini, A., Grosset, D., Valldeoriola, F., Marek, K., Oertel, W., Tolosa, E., Lees, A. J., & Poewe, W. (2007) · Movement Disorders · doi:10.1002/mds.21505 · Cited by 219
Marshall, V. L., Reininger, C. B., Marquardt, M., Patterson, J., Hadley, D. M., Oertel, W. H., Benamer, H. T. S., Kemp, P., Burn, D., Tolosa, E., et al. (2009) · Movement Disorders · doi:10.1002/mds.22108 · Cited by 211
Clinical overview of the synucleinopathies
Mart�, M. J., Tolosa, E., & Campdelacreu, J. (2003) · Movement Disorders · doi:10.1002/mds.10559 · Cited by 203
Simuni, T., Siderowf, A., Lasch, S., Coffey, C. S., Caspell‐Garcia, C., Jennings, D., Tanner, C. M., Trojanowski, J. Q., Shaw, L. M., Seibyl, J., et al. (2018) · Movement Disorders · doi:10.1002/mds.27361 · Cited by 201
Self-citationKim, Y. J., Ichise, M., Ballinger, J. R., Vines, D., Erami, S. S., Tatschida, T., & Lang, A. E. (2002) · Movement Disorders · doi:10.1002/mds.10042 · Cited by 191
Mozley, P. D., Schneider, J. S., Acton, P. D., Plößl, K., Stern, M. B., Siderowf, A. D., Leopold, N. A., Li, P. Y., Alavi, A. A., & Kung, H. F. (2000) · PubMed · Cited by 189
Booij, J., Habraken, J. B. A., Bergmans, P., Tissingh, G., Winogrodzka, A., Wolters, E. C., Janssen, A. G. M., Stoof, J. C., & van Royen, E. A. (1998) · PubMed · Cited by 178
Striatal dopamine in P arkinson disease: A meta‐analysis of imaging studies
Kaasinen, V., & Vahlberg, T. J. (2017) · Annals of Neurology · doi:10.1002/ana.25103 · Cited by 178
Computer-Aided diagnosis of Parkinson’s Disease Using Enhanced Probabilistic Neural Network
Hirschauer, T. J., Adeli, H., & Buford, J. A. (2015) · Journal of Medical Systems · doi:10.1007/s10916-015-0353-9 · Cited by 177
Dopamine transporter imaging with [123I]FP-CIT SPECT: potential effects of drugs
Booij, J., & Kemp, P. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0621-0 · Cited by 175
[ 18 F]FDG-PET is superior to [ 123 I]IBZM-SPECT for the differential diagnosis of parkinsonism
Hellwig, S., Amtage, F., Kreft, A., Buchert, R., Winz, O. H., Vach, W., Spehl, T. S., Rijntjes, M., Hellwig, B., Weiller, C., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826c1b0a · Cited by 174
Longitudinal follow-up of SWEDD subjects in the PRECEPT Study
Marek, K., Seibyl, J., Eberly, S., Oakes, D., Shoulson, I., Lang, A. E., Hyson, C., Jennings, D., & For The Parkinson Study Group PRECEPT Investigators (2014) · Neurology · doi:10.1212/wnl.0000000000000424 · Cited by 168
Self-citationAutopsy validation of 123 I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB
Thomas, A. J., Attems, J., Colloby, S. J., O'Brien, J. T., McKeith, I., Walker, R., Lee, L., Burn, D., Lett, D. J., & Walker, Z. (2017) · Neurology · doi:10.1212/wnl.0000000000003512 · Cited by 165
Seibyl, J. P., MAREK, K. L., Sheff, K., Zoghbi, S. S., Baldwin, R. M., Charney, D. S., van Dyck, C. H., & Innis, R. B. (1998) · PubMed · Cited by 164
Self-citationKumakura, Y., Cumming, P., Vernaleken, I., Buchholz, H.-G., Siessmeier, T., Heinz, A., Kienast, T., Bartenstein, P., & Gründer, G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0805-07.2007 · Cited by 159
Functional Identification and Molecular Cloning of a Human Brain Vesicle Monoamine Transporter
Erickson, J. D., & Eiden, L. E. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07476.x · Cited by 159
PET Tracers for Imaging of the Dopaminergic System
Hatano, K., Ishiwata, K., & Elsinga, P. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777935258 · Cited by 159
[123I]‐FP/CIT SPECT imaging for distinguishing drug‐induced parkinsonism from Parkinson's disease
Lorberboym, M., Treves, T. A., Melamed, E., Lampl, Y., Hellmann, M. A., & Djaldetti, R. (2005) · Movement Disorders · doi:10.1002/mds.20748 · Cited by 154
Progression of monoaminergic dysfunction in parkinson's disease: a longitudinal 18f-dopa pet study
Pavese, N., Rivero-Bosch, M., Lewis, S. J., Whone, A. L., & Brooks, D. J. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.03.012 · Cited by 145
Self-citationTissingh, G., Booij, J., Bergmans, P., Winogrodzka, A., Janssen, A. G. M., van Royen, E. A., Stoof, J. C., & Wolters, E. C. (1998) · PubMed · Cited by 140
Sossi, V., de la Fuente‐Fernández, R., Holden, J. E., et al. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200202000-00011 · Cited by 139
for the EANM-EAN Task Force for the recommendation of FDG PET for Dementing Neurodegenerative Disorders, Walker, Z., Gandolfo, F., Orini, S., Garibotto, V., Agosta, F., Arbizu, J., Bouwman, F. H., Drzezga, A. E., Nestor, P. J., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4031-2 · Cited by 138
Self-citationRibeiro, M. J., Vidailhet, M., Loc’h, C., Dupel, C. P., Nguyen, J. P., Ponchant, M., Dollé, F., Peschanski, M., Hantraye, P., Césaro, P., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.4.580 · Cited by 134
MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis
Treglia, G., Cason, E., Stefanelli, A., Cocciolillo, F., Giuda, D. D., Fagioli, G., & Giordano, A. (2011) · Clinical Autonomic Research · doi:10.1007/s10286-011-0135-5 · Cited by 132
Booij, J., de Jong, J., de Bruin, K. M., Knol, R. J. J., de Win, M. M. L., & van Eck‐Smit, B. L. F. (2007) · PubMed · Cited by 127
Routine quality control recommendations for nuclear medicine instrumentation
Sokole, E. B., With contribution from the EANM Working Group on Nuclear Medicine Instrumentation Quality Control:, Płachcińska, A., Britten, A. J., Georgosopoulou, M. L., Tindale, W., & Klett, R. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1347-y · Cited by 124
Quantification of Dopamine Transporter in Human Brain Using PET with 18F-FE-PE2I
Sasaki, T., Ito, H., Kimura, Y., Arakawa, R., Takano, H., Seki, C., Kodaka, F., Fujie, S., Takahata, K., Nogami, T., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.101626 · Cited by 124
Self-citationVascular P arkinsonism: D econstructing a S yndrome
Vizcarra, J. A., Lang, A. E., Sethi, K. D., & Espay, A. J. (2015) · Movement Disorders · doi:10.1002/mds.26263 · Cited by 121
Booij, J., Hemelaar, T. G., Speelman, J. D., de Bruin, K. M., Janssen, A. G. M., & van Royen, E. A. (1999) · PubMed · Cited by 120
Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia
Rinne, J. O., Laine, M., Kaasinen, V., Norvasuo‐Heilä, M., Någren, K., & Helenius, H. Y. M. (2002) · Neurology · doi:10.1212/wnl.58.10.1489 · Cited by 118
Nobili, F. M., Naseri, M. S. Z., Carli, F. D., Asenbaum, S., Booij, J., Darcourt, J., Ell, P. J., Kapucu, Ö., Kemp, P. M., Claus, V., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2304-8 · Cited by 117
Self-citationGründer, G., Vernaleken, I., Müller, M. J., Davids, E., Heydari, N., Buchholz, H., Bartenstein, P., Munk, O. L., Stoeter, P., Wong, D. F., et al. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300103 · Cited by 115
Calvini, P., Rodriguez, G., Inguglia, F., Mignone, A., Guerra, U. P., & Nobili, F. M. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0357-2 · Cited by 114
Halldin, C., Erixon-Lindroth, N., Pauli, S., Chou, Y.-H., Okubo, Y., Karlsson, P., Lundkvist, C., Olsson, H., Guilloteau, D., Emond, P., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1212-3 · Cited by 114
Brain radioligands--state of the art and new trends.
Halldin, C., Gulyás, B. Z., Langer, O., & Farde, L. (2001) · PubMed · Cited by 111
Quantitative accuracy of dopaminergic neurotransmission imaging with (123)I SPECT.
Soret, M., Koulibaly, P. M., Darcourt, J., Hapdey, S., & Buvat, I. (2003) · PubMed · Cited by 110
Self-citationSafety and tolerability of intracerebroventricular PDGF-BB in Parkinson’s disease patients
Paul, G., Zachrisson, O., Varrone, A., Almqvist, P. M., Jerling, M., Lind, G., Rehncrona, S., Linderoth, B., Bjartmarz, H., Shafer, L. L., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79635 · Cited by 107
Self-citationDopamine Transporter SPECT Imaging in Corticobasal Syndrome
Cilia, R., Rossi, C. A., Frosini, D., Volterrani, D., Siri, C., Pagni, C., Benti, R., Pezzoli, G., Bonuccelli, U., Antonini, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018301 · Cited by 105
Nigrostriatal dopamine transporter availability in early Parkinson's disease
Fazio, P., Svenningsson, P., Cselényi, Z., Halldin, C., Farde, L., & Varrone, A. (2018) · Movement Disorders · doi:10.1002/mds.27316 · Cited by 104
Self-citationBorght, T. M. V., Sima, A. A. F., Kilbourn, M. R., Desmond, T. J., Kuhl, D. E., & Frey, K. A. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00167-h · Cited by 102
Seibyl, J. P., MAREK, K. L., Sheff, K., Baldwin, R. M., Zoghbi, S. S., Zea‐Ponce, Y., Charney, D. S., van Dyck, C. H., Hoffer, P. B., & Innis, R. B. (1997) · PubMed · Cited by 100
Self-citationMeasuring the rate of progression of Parkinson's disease over a 5‐year period with β‐CIT SPECT
Pirker, W., Holler, I., Gerschlager, W., Asenbaum, S., Zettinig, G., & Brücke, T. (2003) · Movement Disorders · doi:10.1002/mds.10531 · Cited by 100
Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT
Morgan, S., Kemp, P. M., Booij, J., Costa, D. C., Padayachee, S., Lee, L., Barber, C., Carter, J., & Walker, Z. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302577 · Cited by 97
Thobois, S., Jahanshahi, M., Pinto, S., Frackowiak, R. S. J., & Limousin, P. D. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.04.039 · Cited by 95
The effect of entacapone (OR‐611) on brain [ 18 F]‐6‐L‐fluorodopa metabolism
Sawle, G. V., Burn, D. J., Morrish, P., Lammertsma, A. A., Snow, B. J., Luthra, S. K., Osman, S., & Brooks, D. J. (1994) · Neurology · doi:10.1212/wnl.44.7.1292 · Cited by 95
Self-citationLorberboym, M., Djaldetti, R., Melamed, E., Sadeh, M., & Lampl, Y. (2004) · PubMed · Cited by 94
Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson’s disease
Eshuis, S. A., Maguire, R. P., Leenders, K. L., et al. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1904-y · Cited by 93
Decreased dopamine transporter availability in male smokers — A dual isotope SPECT study
Yang, Y. K., Yao, W. J., Yeh, T. L., Lee, I. H., Chen, P. S., Lu, R. B., & Chiu, N.-T. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.018 · Cited by 87
Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECT—a clinical comparison
Mo, S. J., Axelsson, J., Jonasson, L. S., Larsson, A., Ögren, M., Ögren, M., Varrone, A., Eriksson, L., Bäckström, D. C., af Bjerkén, S., et al. (2018) · EJNMMI Research · doi:10.1186/s13550-018-0450-0 · Cited by 87
Self-citationMozley, P. D., Stubbs, J. B., Plößl, K., Dresel, S. H. J., Barraclough, E. D., Alavi, A. A., Araujo, L. I., & Kung, H. F. (1998) · PubMed · Cited by 86
[3H]Dihydrotetrabenazine, a New In Vitro Monoaminergic Probe for Human Brain
Scherman, D., Raisman‐Vozari, R., Ploska, A., & Agid, Y. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb10583.x · Cited by 85
Brigo, F., Matinella, A., Erro, R., & Tinazzi, M. (2014) · European Journal of Neurology · doi:10.1111/ene.12444 · Cited by 84
Takikawa, S., DHAWAN, V. M., Chaly, T., Robeson, W., Dahl, R. A., ZANZI, I., Mandel, F. S., Spetsieris, P. G., & Eidelberg, D. (1994) · PubMed · Cited by 84
Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?
Arnaldi, D., Carli, F. D., Picco, A., Ferrara, M., Accardo, J., Bossert, I., Famà, F., Girtler, N. G., Morbelli, S. D., Sambuceti, G., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.08.025 · Cited by 81
Self-citationThe impact of reconstruction method on the quantification of DaTSCAN images
Dickson, J. C., Tossici-Bolt, L., Séra, T., Erlandsson, K., Varrone, A., Tatsch, K., & Hutton, B. F. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1212-z · Cited by 81
Self-citationApplication of texture analysis to DAT SPECT imaging: Relationship to clinical assessments
Rahmim, A., Salimpour, Y., Jain, S., Blinder, S. A. L., Klyuzhin, I. S., Smith, G. S., Mari, Z. K., & Sossi, V. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.02.012 · Cited by 78
Separating Parkinson's Disease From Normality
Sawle, G. V. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540150027011 · Cited by 76
Miyoshi, M., Shinotoh, H., Wszolek, Z. K., Strongosky, A. J., Shimada, H., Arakawa, R., Higuchi, M., Ikoma, Y., Yasuno, F., Fukushi, K., et al. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.04.004 · Cited by 75
Varrone, A., Steiger, C., Schou, M., Takano, A., Finnema, S. J., Guilloteau, D., Gulyás, B. Z., & Halldin, C. (2009) · Synapse · doi:10.1002/syn.20670 · Cited by 75
Self-citationBauckneht, M., Chincarini, A., Carli, F. D., Terzaghi, M., Morbelli, S. D., Nobili, F. M., & Arnaldi, D. (2018) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2018.04.001 · Cited by 73
Self-citationJokinen, P., Helenius, H., Rauhala, E., Brück, A., Eskola, O., & Rinne, J. O. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.061572 · Cited by 72
van der Zande, J. J., Booij, J., Scheltens, P., Raijmakers, P. G. H. M., & Lemstra, A. W. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3312-x · Cited by 70
11C‐PE2I and 18F‐Dopa PET for assessing progression rate in Parkinson's: A longitudinal study
Li, W., Lao–Kaim, N. P., Roussakis, A., Martín‐Bastida, A., Guzman, N. V., Paul, G., Loane, C., Widner, H., Politis, M., Foltynie, T., et al. (2017) · Movement Disorders · doi:10.1002/mds.27183 · Cited by 70
Hirvonen, J., Johansson, J. J., Teräs, M., Oikonen, V., Lumme, V., Virsu, P., Roivainen, A., Någren, K., Halldin, C., Farde, L., et al. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600607 · Cited by 68
Jučaitė, A., Odano, I., Olsson, H., Pauli, S., Halldin, C., & Farde, L. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-0027-9 · Cited by 67
Laere, K. V., Varrone, A., Booij, J., Borght, T. V., Nobili, F. M., Ozlem Kapucu, L., Walker, Z., Någren, K., Tatsch, K., & Darcourt, J. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1265-z · Cited by 66
Self-citationBooij, J., Dubroff, J. G., Pryma, D. A., Yu, J. Q., Agarwal, R., Lakhani, P. C., & Kuo, P. H. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.189266 · Cited by 65
Self-citationVarrone, A., Tóth, M., Steiger, C., Takano, A., Guilloteau, D., Ichise, M., Gulyás, B. Z., & Halldin, C. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.077651 · Cited by 61
Self-citationFazio, P., Svenningsson, P., Forsberg, A., Jönsson, E. G., Amini, N., Nakao, R., Nag, S., Halldin, C., Farde, L., & Varrone, A. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.152421 · Cited by 61
Self-citationWhat predicts cognitive decline in de novo Parkinson's disease?
Arnaldi, D., Campus, C., Ferrara, M., Famà, F., Picco, A., Carli, F. D., Accardo, J., Brugnolo, A., Sambuceti, G., Morbelli, S. D., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.11.028 · Cited by 56
Self-citationTiraboschi, P., Corso, A., Guerra, U. P., Nobili, F. M., Piccardo, A., Calcagni, M. L., Volterrani, D., Cecchin, D., Tettamanti, M., Antelmi, L., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24717 · Cited by 56
Dickson, J. C., Tossici-Bolt, L., Séra, T., de Nijs, R., Booij, J., Bagnara, M. C., Seese, A., Koulibaly, P. M., Akdemir, Ü. Ö., Jonsson, C., et al. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1884-z · Cited by 52
Self-citationSeibyl, J. P., Wallace, E. A., Smith, E. O., Stabin, M., Baldwin, R. M., Zoghbi, S. S., Zea‐Ponce, Y., Gao, Y., Zhang, W. Y., & Neumeyer, J. L. (1994) · PubMed · Cited by 50
Self-citationDopamine Function in Cigarette Smokers: An [18F]-DOPA PET Study
Bloomfield, M. A., Pepper, F., Egerton, A., Demjaha, A., Tomasi, G., Mouchlianitis, E., Maximen, L., Veronese, M., Turkheimer, F., Selvaraj, S., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.87 · Cited by 48
Use of 11C-PE2I PET in Differential Diagnosis of Parkinsonian Disorders
Appel, L., Jonasson, M., Danfors, T., Nyholm, D., Askmark, H., Lubberink, M., & Sørensen, J. A. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.148619 · Cited by 46
Correlation between quantitative imaging and behavior in unilaterally 6-OHDA-lesioned rats
Inaji, M., Okauchi, T., Ando, K., Maeda, J., Nagai, Y., Yoshizaki, T., Okano, H., Nariai, T., Ohno, K., Obayashi, S., et al. (2005) · Brain Research · doi:10.1016/j.brainres.2005.09.055 · Cited by 44
The dosimetry of iodine-123 labelled 2?-carbomethoxy-3?-(4-iodophenyl)tropane
Kuikka, J., Bergstr�m, K. A., Ahonen, A. K., et al. (1994) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00182306 · Cited by 43
DeLorenzo, C., Kumar, J. D., Zanderigo, F., Mann, J. J., & Parsey, R. V. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.49 · Cited by 41
Association of central serotonin transporter availability and body mass index in healthy Europeans
Hesse, S., van de Giessen, E., Zientek, F., Petroff, D., Winter, K., Dickson, J. C., Tossici-Bolt, L., Séra, T., Asenbaum, S., Darcourt, J., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.05.005 · Cited by 40
Self-citationSchäfer, M. K.-H., Hartwig, N. R., Kalmbach, N., Klietz, M., Anlauf, M., Eiden, L. E., & Weihe, E. (2013) · Diabetologia · doi:10.1007/s00125-013-2847-7 · Cited by 36
Felicio, A. C., Godeiro-Junior, C. D. O., Moriyama, T. S., Shih, M. C., Hoexter, M. Q., Borges, V., Silva, S. M. A., Aguiar, P. D. C., Andrade, L. E. C., Bressan, R. A., et al. (2010) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2009.12.010 · Cited by 35
Lin, K., Weng, Y.-H., Hsieh, C., Lin, W., Wey, S., Kung, M., Yen, T., Lu, C., & Hsiao, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075952 · Cited by 34
I‐123 DaTscan SPECT Brain Imaging in Parkinsonian Syndromes: Utility of the Putamen‐to‐Caudate Ratio
Matesan, M. C., Gaddikeri, S., Longfellow, K., Miyaoka, R. S., Elojeimy, S. N., Elman, S., Hu, S., Minoshima, S., & Lewis, D. (2018) · Journal of Neuroimaging · doi:10.1111/jon.12530 · Cited by 32
Sonni, I., Fazio, P., Schain, M., Halldin, C., Svenningsson, P., Farde, L., & Varrone, A. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.171231 · Cited by 29
Self-citationBrain PET imaging optimization with time of flight and point spread function modelling
Prieto, E., Martí-Climent, J. M., Morán, V., Sancho, L., Barbés, B., Arbizu, J., & Richter, J. Á. (2015) · Physica Medica · doi:10.1016/j.ejmp.2015.07.001 · Cited by 27
Self-citationAznavour, N., Cendrès-Bozzi, C., Lemoine, L., et al. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12009 · Cited by 27
Kishore, A., Wszołek, Z. K., Snow, B. J., de la Fuente‐Fernández, R., Arwert, F., Wijker, M., Schulzer, M., Calne, D. B., & Vingerhoets, F. J. G. (1996) · Neurology · doi:10.1212/wnl.47.6.1588 · Cited by 27
Murthy, R., Harris, P. E., Simpson, N. R., et al. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0648-2 · Cited by 25
The neuropathologic diagnosis of secondary parkinsonian syndromes.
Jellinger, K. A. (1996) · PubMed · Cited by 23
Nagaki, A., Onoguchi, M., & Matsutomo, N. (2014) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000187 · Cited by 21
Nicastro, N., Garibotto, V., & Burkhard, P. R. (2017) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001899 · Cited by 19
Self-citationIs dopamine transporter invariably impaired at the time of diagnosis in dementia with Lewy bodies?
Nobili, F. M., Arnaldi, D., & Morbelli, S. D. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3323-7 · Cited by 14
Self-citationHsu, C., Chang, Y.-H., Lin, W., Tang, S.-W., Wang, P., Huang, Y., & Chiu, N.-T. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/879497 · Cited by 13
(2002) · PubMed
Cited by
EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3
Guedj, E., Varrone, A., Boellaard, R., Albert, N. L., Barthel, H., van Berckel, B., Brendel, M., Cecchin, D., Ekmekcioglu, O., Garibotto, V., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05603-w · Cited by 300
Self-citationNuclear medicine and molecular imaging advances in the 21st century
Vaz, S. C., Oliveira, F., Herrmann, K., & Veit-Haibach, P. (2020) · The British Journal of Radiology · doi:10.1259/bjr.20200095 · Cited by 86
Metadata
- Authors
- Morbelli, S., Esposito, G., Arbizu, J., Barthel, H., Boellaard, R., Bohnen, N. I., Brooks, D. J., Darcourt, J., Dickson, J. C., Douglas, D., Drzezga, A., Dubroff, J., Ekmekcioglu, O., Garibotto, V., Herscovitch, P., Kuo, P., Lammertsma, A., Pappata, S., Peñuelas, I., Seibyl, J., Semah, F., Tossici-Bolt, L., Van de Giessen, E., Van Laere, K., Varrone, A., Wanner, M., Zubal, G., & Law, I.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2020-05-09
- Volume
- 47
- Issue
- 8
- Pages
- 1885-1912
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W2954129211
- Cited by
- 273
- References
- 127
- FWCI
- 12.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.